Algeta to Participate in Upcoming Investor Conferences
(Thomson Reuters ONE) -
Oslo, Norway, 5 November 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that members of
its executive management team will participate in the following upcoming
investor conferences:
Credit Suisse Healthcare Conference 2013
Date: 12-14 November 2013
Participants:
Jeff Albers (President, Algeta US)
Mike Booth (SVP, Communications)
Venue: Scottsdale, AZ, USA
DNB Markets Health Care Conference
Date: 27 November 2013
Participants:
Andrew Kay (President & CEO)
Thomas Ramdahl (Executive VP and COO)
Venue: Oslo, Norway
Deutsche Bank dbAccess Pharmaceutical Corporate Day
Date: 5 December 2013
Participants:
Andrew Kay (President & CEO)
Mike Booth (SVP, Communications)
Venue: London, UK
SEB Securities Best of Norway Day
Date: 12 December 2013
Participants:
Mike Booth (SVP, Communications)
Venue: New York, NY, USA
Presentations, where applicable, will be available to download at www.algeta.com
following these events.
###
For further information, please contact:
Mike Booth +1 646 410 1884
Communications & Corporate Affairs ir(at)algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson mark.swallow(at)citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton knut.ekern(at)hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications kwatson(at)macbiocom.com
Investor enquiries:
Tricia Truehart +1 646 378 2953
The Trout Group ttruehart(at)troutgroup.com
About Algeta
Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Press release:
http://hugin.info/134655/R/1740507/584542.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1740507]
Unternehmensinformation / Kurzprofil:
Datum: 05.11.2013 - 07:00 Uhr
Sprache: Deutsch
News-ID 312568
Anzahl Zeichen: 3720
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 220 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Algeta to Participate in Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Algeta ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
